References
- Lepine JP, Briley M. The increasing burden of depression. Neuropsychiatr Dis Treat 2011; 7(Suppl. 1): S3–S7.
- Vos T, Haby MM, Barendregt JJ, Kruijshaar M, Corry J, Andrews G. The burden of major depression avoidable by longer-term treatment strategies. Arch Gen Psychiatry 2004; 61(11): 1097–103. [CrossRef]
- Hardeveld F, Spijker J, De Graaf R, Nolen WA, Beekman ATF. Prevalence and predictors of recurrence of major depressive disorder in the adult population. Acta Psychiatrica Scandinavica 2010; 122(3): 184–91. [CrossRef]
- Bockting CL, Kok GD, van der Kamp L, Smit F, van Valen E, Schoevers R, et al. Disrupting the rhythm of depression using Mobile Cognitive Therapy for recurrent depression: randomized controlled trial design and protocol. BMC Psychiatry 2011; 11:12. doi:10.1186/1471-244X-11-12. [CrossRef]
- Patten SB, Kennedy SH, Lam RW, O'Donovan C, Filteau MJ, Parikh SV et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. I. Classification, burden and principles of management. J Affect Disord 2009; 117(Suppl. 1): S5–S14. [CrossRef]
- Ravindran AV, Lam RW, Filteau MJ, Lesperance F, Kennedy SH, Parikh SV et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. V. Complementary and alternative medicine treatments. J Affect Disord 2009; 117(Suppl. 1): S54–S64. [CrossRef]
- Linde K, Berner M, Kriston L. St John's wort for major depression. Cochrane Database Syst Rev 2008; 4:CD000448. doi:10.1002/14651858.CD00048.pub3.
- Kasper S, Caraci F, Forti B, Drago F, Aguglia E. Efficacy and tolerability of Hypericum extract for the treatment of mild to moderate depression. Eur Neuropsychopharmacol 2010; 20(11): 747–65. [CrossRef]
- Sheldon RC. St John's wort (Hypericum perforatum) in major depression. J Clin Psychiatry 2009; 70(Suppl. 5): S23–S7. [CrossRef]
- Linde K. St. John's wort—an overview. Forsch Komplementarmed 2009; 16(3): 146–55. [CrossRef]
- Brattström A. Long-term effects of St. John's wort (Hypericum perforatum) treatment: a 1-year safety study in mild to moderate depression. Phytomedicine 2009; 16(4): 277–83. [CrossRef]
- Singer A, Schmidt M, Hauke W, Stade K. Duration of response after treatment of mild to moderate depression with Hypericum extract STW 3-VI, citalopram and placebo: a reanalysis of data from a controlled clinical trial. Phytomedicine 2011; 18(8–9): 739–42. [CrossRef]
- Kasper S, Volz HP, Möller HJ, Dienel A, Kieser M. Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after recovery from an acute episode of moderate depression—a double-blind, randomized, placebo controlled long-term trial. Eur Neuropsychopharmacol 2008; 18(11): 803–13. [CrossRef]
- American Psychiatric Association. Practice Guideline for the Treatment of Patients with Major Depressive Disorder, 3rd Edition. Arlington, American Psychiatric Association, 2010. http://www.psychiatryonline.org/guidelines. doi:10.1176/appi.books.9780890423387.654001